EI
ELV icon

Ethic Inc’s Elevance Health ELV Stock Holding History

Ethic Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
34,237
+1,417
+4% +$526K 0.17% 116
2026
Q1 		$9.61M Sell
32,820
-4,433
-12% -$1.46M 0.15% 141
2025
Q4 		$13.1M Buy
37,253
+4,245
+13% +$1.43M 0.2% 95
2025
Q3 		$10.7M Sell
33,008
-6,761
-17% -$2.1M 0.18% 119
2025
Q2 		$15.2M Buy
39,769
+2,564
+7% +$1.03M 0.27% 66
2025
Q1 		$16.1M Buy
37,205
+12,806
+52% +$5.14M 0.33% 51
2024
Q4 		$9M Buy
24,399
+5,471
+29% +$2.29M 0.18% 112
2024
Q3 		$9.82M Sell
18,928
-6,118
-24% -$3.27M 0.25% 75
2024
Q2 		$13.6M Buy
25,046
+6,118
+32% +$3.23M 0.32% 60
2024
Q1 		$9.82M Sell
18,928
-4,858
-20% -$2.42M 0.25% 75
2023
Q4 		$11.2M Buy
23,786
+2,494
+12% +$1.15M 0.33% 53
2023
Q3 		$9.27M Buy
21,292
+1,831
+9% +$831K 0.33% 55
2023
Q2 		$8.65M Buy
19,461
+701
+4% +$323K 0.32% 60
2023
Q1 		$8.63M Buy
18,760
+65
+0.3% +$30.9K 0.35% 52
2022
Q4 		$9.59M Buy
18,695
+3,099
+20% +$1.57M 0.52% 30
2022
Q3 		$7.08M Buy
15,596
+1,489
+11% +$712K 0.48% 29
2022
Q2 		$6.81M Buy
14,107
+2,914
+26% +$1.44M 0.47% 35
2022
Q1 		$5.5M Buy
11,193
+1,741
+18% +$796K 0.38% 50
2021
Q4 		$4.38M Buy
9,452
+1,654
+21% +$696K 0.34% 66
2021
Q3 		$2.91M Buy
7,798
+971
+14% +$369K 0.3% 79
2021
Q2 		$2.61M Buy
6,827
+1,784
+35% +$682K 0.32% 71
2021
Q1 		$1.81M Buy
5,043
+1,908
+61% +$614K 0.32% 71
2020
Q4 		$1.01M Buy
3,135
+465
+17% +$143K 0.27% 91
2020
Q3 		$717K Buy
2,670
+492
+23% +$132K 0.27% 95
2020
Q2 		$573K Buy
2,178
+607
+39% +$162K 0.33% 77
2020
Q1 		$357K Buy
1,571
+232
+17% +$63.2K 0.3% 113
2019
Q4 		$404K Buy
+1,339
New +$368K 0.3% 112

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ethic Inc's ELV Position: Q2 2026 in Review

Ethic Inc increased its Elevance Health (ELV) stake by 4.3% in Q2 2026, buying an estimated $526K and bringing the position to 34,237 shares worth $13.2M. The position accounts for 0.17% of the portfolio, ranked #116.

Ethic Inc first reported a position in ELV in Q4 2019 and has held it in 27 quarters since. The position peaked at $16.1M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ethic Inc held 34,237 shares of Elevance Health worth $13.2M as of Q2 2026.
  • Ethic Inc bought 1,417 Elevance Health shares in Q2 2026, an estimated $526K.
  • Elevance Health made up 0.17% of Ethic Inc's portfolio in Q2 2026, its #116 holding.
  • Ethic Inc first reported a position in Elevance Health in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's Elevance Health position peaked at $16.1M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.